Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice

International Immunology

Volumn 22, Issue 3, 2010, Pages 179-189

  Ozeki, Yuriko ^a,b   Sugawara, Isamu ^c   Udagawa, Tadashi ^c   Aoki, Toshiaki ^c   Osada Oka, Mayuko ^a   Tateishi, Yoshitaka ^a   Hisaeda, Hajime ^d   Nishiuchi, Yuji ^e   Harada, Nobuyuki ^c   Kobayashi, Kazuo ^f   Matsumoto, Sohkichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sonoda Women's University   (Japan)

^c RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e Protein Research Foundation   (Japan)

^f NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Bacterial; Inflammation; Lung; Rodent; T cells

Indexed keywords

TUBERCULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL MOUSE; FEMALE; GRANULOMA; HISTOPATHOLOGY; LYMPHOCYTE DEPLETION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SURVIVAL RATE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, SCID; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TUBERCULIN; TUBERCULOSIS;

EID: 77949890194     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp126     Document Type: Article

References (44)

1. Dye, C., Scheele, S., Dolin, P., Pathania, V. and Raviglione, M. C. 1999. Consensus statement. Global burden of tuberculosis:estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677.
2. Jouanguy, E., Altare, F., Lamhamedi, S. et al. 1996. Interferongamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335:1956.
3. Newport, M. J., Huxley, C. M., Huston, S. et al. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941.
4. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455.
5. Sakaguchi, S. 2004. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531.
6. Shevach, E. M. 2001. Certified professionals: CD4(+)CD25(+) suppressor T cells. J. Exp. Med. 193:F41.
7. Read, S., Malmstrom, V. and Powrie, F. 2000. Cytotoxic T lymphocyte-associated antigen plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295.
8. Takahashi, T., Tagami, T., Yamazaki, S. et al. 2000. Immunologicself-tolerance maintained by CD25(+)CD4(+) regulatory T cellsconstitutively expressing cytotoxic T lymphocyte-associated antigen4. J. Exp. Med. 192:303.
9. Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. and Sakaguchi, S. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3:135.
10. McHugh, R. S., Whitters, M. J., Piccirillo, C. A. et al. 2002. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311.
11. Hori, S., Nomura, T. and Sakaguchi, S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057.
12. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M. 2008. Regulatory T cells and immune tolerance. Cell 133:775.
13. Asseman, C., Mauze, S., Leach,M.W., Coffman, R. L. and Powrie, F. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995.
14. Gorelik, L. and Flavell, R. A. 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12:171.
15. Takahashi, T., Kuniyasu, Y., Toda, M. et al. 1998. Immunologic selftolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10:1969.
16. Thornton, A. M. and Shevach, E. M. 1998. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
17. Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M. and Sacks, D. L. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420:502.
18. Suvas, S., Kumaraguru, U., Pack, C. D., Lee, S. and Rouse, B. T. 2003. CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J. Exp. Med. 198:889.
19. Aandahl, E. M., Michaelsson, J., Moretto, W. J., Hecht, F. M. and Nixon, D. F. 2004. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:2454.
20. + T cells. Infect. Immun. 71:1755.
21. + regulatory T cells. Nat. Med. 10:29.
22. Kursar, M., Koch, M., Mittrucker, H. W. et al. 2007. Cutting Edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 178:2661.
23. Quinn, K. M., McHugh, R. S., Rich, F. J. et al. 2006. Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol. Cell Biol. 84:467.
24. Quinn, K. M., Rich, F. J., Goldsack, L. M. et al. 2008. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis. Eur. J. Immunol. 38:695.
25. Scott-Browne, J. P., Shafiani, S., Tucker-Heard, G. et al. 2007. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 204:2159.
26. Kaneko, H., Yamada, H., Mizuno, S. et al. 1999. Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice. Lab. Invest. 79:379.
27. Pasare, C. and Medzhitov, R. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033.
28. Flynn, J. L. and Chan, J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93.
29. Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M. and Demengeot, J. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197:403.
30. Crellin, N. K., Garcia, R. V., Hadisfar, O., Allan, S. E., Steiner, T. S. and Levings, M. K. 2005. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J. Immunol. 175:8051.
31. Peng, G., Guo, Z., Kiniwa, Y. et al. 2005. Toll-like receptor 8- mediated reversal of CD4+ regulatory T cell function. Science 309:1380.
32. Sutmuller, R. P., den Brok, M. H., Kramer, M. et al. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116:485.
33. Bafica, A., Scanga, C. A., Feng, C. G., Leifer, C., Cheever, A. and Sher, A. 2005. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202:1715.
34. Thoma-Uszynski, S., Stenger, S., Takeuchi, O. et al. 2001.Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291:1544.
35. North, R. J. and Jung, Y. J. 2004. Immunity to tuberculosis. Annu. Rev. Immunol. 22:599.
36. Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A. and Bloom, B. R. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249.
37. Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G. and Orme, I. M. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243.
38. Scanga, C. A., Mohan, V. P., Yu, K. et al. 2000. Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J. Exp. Med. 192:347.
39. Jung, Y. J., LaCourse, R., Ryan, L. and North, R. J. 2002. Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice. Infect. Immun. 70:6436.
40. Behr, M. A., Wilson, M. A., Gill, W. P. et al. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520.
41. Lund, J. M., Hsing, L., Pham, T. T. and Rudensky, A. Y. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320:1220.
42. Roberts, T., Beyers, N., Aguirre, A. and Walzl, G. 2007. Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factorbeta, and interleukin-4 mRNA levels. J. Infect. Dis. 195:870.
43. Nishikawa, H., Kato, T., Tawara, I. et al. 2005. Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells. J. Exp. Med. 201:681.
44. Mendez, S., Reckling, S. K., Piccirillo, C. A., Sacks, D. and Belkaid, Y. 2004. Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 200:201